diagnostics-1
26 November 2013Americas

FDA orders 23andMe to cease PGS sales

The US Food and Drug Administration (FDA) has told genetics company 23andMe to stop selling its Personal Genome Service (PGS) product immediately.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
27 July 2018   GSK revealed its new approach to research and development earlier this week, including a partnership with DNA testing company 23andMe.

More on this story

Americas
27 July 2018   GSK revealed its new approach to research and development earlier this week, including a partnership with DNA testing company 23andMe.

More on this story

Americas
27 July 2018   GSK revealed its new approach to research and development earlier this week, including a partnership with DNA testing company 23andMe.